1. Ardalan B, Singh G, Silberman H (1988) A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonoacetyl)-L-Aspartic acid in patients with advanced pancreatic and colorectal cancers. J Clin Oncol 6: 1053–1058
2. Ausman R, Caballero G, Quebbeman E (1985) Response of metastatic colorectal adenocarcinomas to long term continuous ambulatory infusion (CAII) of 5-fluorouracil (5-FU). Proc Am Soc Clin Oncol 4: C-336 (abstr)
3. Belt RJ, Davidner ML, Myron MC (1985) Continuous low dose 5-fluorouracil for adenocarcinoma: confirmation of activity. Proc Am Soc Clin Oncol 4: C-349 (abstr)
4. Benedetto P, Davilla E, Solomon J (1984) Chronic continuous Infusion of 5-fluorouracil (CCI-5-FU) in the treatment of metastatic colorectal carcinoma (CCR). Proc Am Soc Clin Oncol 3: C-556 (abstr)
5. Bruckner HW, Roboz J, Spigelman M (1984) An efficient leucovorin-5-fluorouracil sequence: dosage escalation and pharmacologic monitoring. Adv in Cancer Chemother 49–53